Lowdermilk Mary Madelyn, Evanovich Devon Michael, Wang Jue Teresa, Pier Danielle Bennett, Sadhwani Anjali, Zendejas Benjamin, Bajic Dusica
Tufts University School of Medicine, Boston, MA, United States.
Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, MA, United States.
Front Pediatr. 2025 Feb 28;13:1527880. doi: 10.3389/fped.2025.1527880. eCollection 2025.
With increased survival of infants born with esophageal atresia (EA), there is a knowledge gap regarding neurodevelopmental outcomes. We aimed to quantify the frequency of (1) documented developmental delay, and (2) implementation of early intervention services in the first and the second year of life following repair of and EA.
We retrospectively analyzed term-born ( = 44) and premature infants ( = 26) following EA repair at a single institution (2009-2020). Infants with anomalies associated with known neurological disorders were excluded. Clinical data was obtained from the electronic medical record, and presented as means and percentages. Developmental delay included clinically documented motor, speech/language, and cognitive delays that were stratified according to a surgical group: and EA.
Nearly half of (24/54; ) and most of EA patients (12/16; ) had documented developmental delay in the first year of life that persisted into the second year of life [ [28/54] ; [11/16] EA]. Developmental delay was noted irrespective of gestational age at birth, co-existing cardiac anomalies, or presence of cranial/brain findings on imaging. By age 2, (38/54) of and (11/16) of EA patients had received early intervention.
Infants born with EA are at high-risk for developmental delay. Early neurodevelopmental assessments and intervention is recommended for EA patients.
随着食管闭锁(EA)患儿存活率的提高,关于神经发育结局存在知识空白。我们旨在量化以下情况的发生率:(1)记录在案的发育迟缓,以及(2)在EA修复后的第一年和第二年实施早期干预服务的情况。
我们回顾性分析了在单一机构(2009 - 2020年)接受EA修复的足月儿(n = 44)和早产儿(n = 26)。排除患有与已知神经系统疾病相关异常的婴儿。临床数据从电子病历中获取,并以均值和百分比表示。发育迟缓包括临床记录的运动、言语/语言和认知延迟,这些延迟根据手术分组进行分层:EA和EA。
近一半的EA患者(24/54;44%)和大多数EA患者(12/16;75%)在生命的第一年有记录在案的发育迟缓,并持续到第二年[EA患者中为28/54(52%);EA患者中为11/16(69%)]。无论出生时的胎龄、并存的心脏异常或影像学上有无颅骨/脑部异常,均发现有发育迟缓。到2岁时,EA患者中有(38/54)和EA患者中有(11/16)接受了早期干预。
EA患儿发育迟缓风险高。建议对EA患者进行早期神经发育评估和干预。